If there are some positives from the current trials, does this FDA proposal, which has a 60 day comment period, accelerate the traectory of PBT? Does it lessen the requirements for a phase 111 before approvals?
fda proposes to lower the bar on alzheimer's d, page-2
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $184 | 36.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 69333674 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 38960980 | 25 |
View Market Depth
| Last trade - 10.03am 10/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |